Literature DB >> 217572

Urinary excretion of mecillinam by volunteers receiving film-coated tablets of pivmecillinam hydrochloride.

J D Anderson, M A Adams.   

Abstract

Mecillinam is a new amidinopenicillin which is taken orally as its ester pivmecillinam. 10 healthy volunteers were each given 200 mg of pivmecillinam hydrochloride four times daily and all urine was collected and cooled to -20 degrees C to minimize antibiotic degradation. 43% of the ingested antibiotic was recovered from the urine in its microbiologically active form, during the first 12 h and 34% during the subsequent 24 h. The corresponding figures for 10 volunteers receiving double this dose of antibiotic was 30 and 34%. The mean half life of mecillinam in urine due to spontaneous breakdown at 37 degrees C was 17 h. There was evidence that stearate-film-coated pivmecillinam hydrochloride tablets may be less likely to cause dyspepsia than gelatine capsules.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 217572     DOI: 10.1159/000237814

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  2 in total

1.  Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project.

Authors:  Sven A Ferry; Stig E Holm; Hans Stenlund; Rolf Lundholm; Tor J Monsen
Journal:  Scand J Prim Health Care       Date:  2007-03       Impact factor: 2.581

2.  Pivmecillinam for Uncomplicated Lower Urinary Tract Infections Caused by Staphylococcus saprophyticus-Cumulative Observational Data from Four Recent Clinical Studies.

Authors:  Filip Jansåker; Marianne Bollestad; Ingvild Vik; Morten Lindbæk; Lars Bjerrum; Niels Frimodt-Møller; Jenny Dahl Knudsen
Journal:  Antibiotics (Basel)       Date:  2019-05-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.